To support this hypothesis the evidence showed that MSI-positive CRC are less likely to carry mutations of TP53, KRAS and DCC genes, which are usually associated with uncontrolled cell proliferation and poor prognosis [22–24]. The gene discussed is KRAS; the disease is colorectal carcinoma.